List of insiders holdings for CODEXIS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Equilon Enterprises LLC 10% Owner | 2011-05-24 11:17:40 | 11,146,638 0 | 11,146,638 | Form 4 |
| Shell Brazil Holding B.V. 10% Owner | 2011-06-02 09:19:13 | 11,146,638 0 | 11,146,638 | Form 4 |
| SULAT JAMES R Director 10% Owner | 2010-04-29 21:44:56 | 30,816 5,957,108 | 5,987,924 | Form 4 |
| MAXYGEN INC 10% Owner | 2010-12-17 09:38:27 | 5,969,917 0 | 5,969,917 | Form 4 |
| Raizen Energia Participacoes S.A. Ispagnac Participacoes Ltda. Royal Dutch Shell plc Cosan S.A. Industria e Comercio Cosan Ltd. 10% Owner | 2011-06-07 16:50:48 | 5,573,319 0 | 5,573,319 | Form 13D |
| Vivo Ventures Fund VII L.P. Vivo Ventures VII Affiliates Fund L.P. VIVO VENTURES VII LLC 10% Owner | 2019-02-14 15:18:59 | 2,620,530 0 | 2,620,530 | Form 13G |
| DILLY STEPHEN GEORGE See Remarks | 2024-01-02 21:23:40 | 1,442,803 0 | 1,442,803 | Form 4 |
| NICOLS JOHN J Director | 2023-04-19 16:18:46 | 1,105,391 0 | 1,105,391 | Form 4 |
| Ryali Sriram Chief Financial Officer | 2024-01-02 21:24:26 | 489,916 0 | 489,916 | Form 4 |
| Norrett Kevin Chief Operating Officer | 2024-01-02 21:24:10 | 464,577 0 | 464,577 | Form 4 |
| Fitzgerald Margaret Nell See Remarks | 2024-01-02 21:23:56 | 447,895 0 | 447,895 | Form 4 |
| SHAW ALAN President and CEO | 2011-12-19 17:41:20 | 75,000 202,000 | 277,000 | Form 4 |
| Sheehy Douglas T. See Remarks | 2016-03-08 18:46:01 | 247,617 0 | 247,617 | Form 4 |
| SANGSTER GORDON SVP & Chief Financial Officer | 2019-03-22 18:25:08 | 235,453 0 | 235,453 | Form 4 |
| KELLEY BERNARD J Director | 2021-08-12 16:13:46 | 206,136 0 | 206,136 | Form 4 |
| Aldridge Michael D. See Remarks | 2018-05-18 17:54:46 | 206,000 0 | 206,000 | Form 4 |
| Dorgan Byron L Director | 2023-11-17 17:14:12 | 193,461 0 | 193,461 | Form 4 |
| Seufer-Wasserthal Peter SVP, Pharmaceuticals | 2013-01-28 21:25:24 | 158,950 0 | 158,950 | Form 4 |
| Sarret Joseph J. SVP and CBO | 2012-03-09 19:42:44 | 133,000 13,333 | 146,333 | Form 4 |
| Lalonde James SVP, R&D | 2019-05-15 16:23:02 | 135,780 0 | 135,780 | Form 4 |
| Smith David V Director | 2023-06-15 16:06:45 | 34,602 88,570 | 123,172 | Form 4 |
| O'Toole David D SVP & Chief Financial Officer | 2013-09-06 19:14:06 | 110,687 0 | 110,687 | Form 4 |
| Anton David L. SVP, BioIndustrials | 2013-02-12 21:23:02 | 93,777 0 | 93,777 | Form 4 |
| Tobin Matthew SVP, Research & Development | 2013-05-17 21:03:59 | 78,707 0 | 78,707 | Form 4 |
| Karsner Alexander Director | 2014-01-06 18:15:46 | 78,519 0 | 78,519 | Form 4 |
| WOLF DENNIS P Director | 2023-06-15 16:10:06 | 76,800 0 | 76,800 | Form 4 |
| PARKER H STEWART Director | 2023-06-15 16:08:26 | 72,480 0 | 72,480 | Form 4 |
| Cheng Pam P. Director | 2019-06-13 16:11:26 | 69,589 0 | 69,589 | Form 4 |
| MOORE ALISON Director | 2023-06-15 16:09:10 | 68,576 0 | 68,576 | Form 4 |
| Glaub Kathleen Sereda Director | 2019-06-13 16:12:42 | 68,481 0 | 68,481 | Form 4 |
| Aaker Jennifer Director | 2023-06-15 16:11:01 | 66,211 0 | 66,211 | Form 4 |
| Strumph Peter M Interim President and CEO | 2012-06-05 18:14:33 | 60,756 0 | 60,756 | Form 4 |
| Martinborough Esther Director | 2023-06-15 16:10:33 | 57,933 0 | 57,933 | Form 4 |
| Yang Patrick Y Director | 2022-06-16 16:14:10 | 53,785 0 | 53,785 | Form 4 |
| Lawson Robert J SVP and CFO | 2011-05-12 21:26:48 | 44,000 0 | 44,000 | Form 4 |
| TAYLOR DEAN ROSS JR Advisor | 2023-02-09 16:21:47 | 38,554 0 | 38,554 | Form 4 |
| Ho Mark Principal Accounting Officer | 2012-07-17 18:20:54 | 34,090 0 | 34,090 | Form 3 |
| BARUCH THOMAS R Director | 2020-06-16 16:03:50 | 33,093 0 | 33,093 | Form 4 |
| Dowd Brian Paul Interim CFO | 2012-06-05 18:14:18 | 28,310 0 | 28,310 | Form 4 |
| Pasternack Bruce A Director | 2010-08-27 21:11:28 | 10000 0 | 10000 | Form 4 |
| Singhvi Rahul Director | 2023-11-14 18:21:39 | 10000 0 | 10000 | Form 4 |
| Streng Chris Director | 2010-04-21 20:37:41 | 0 0 | 0 | Form 3 |
| Biomedical Sciences Investment Fund Pte Ltd. EDB Investments Pte Ltd. 10% Owner | 2018-02-12 06:08:14 | 0 0 | 0 | Form 13G |
| Wong Mun Yew Director | 2010-04-29 21:49:01 | 0 0 | 0 | Form 4 |
| CMEA VENTURES LIFE SCIENCES 2000 LP CMEA Ventures Life Sciences 2000 Civil Law Partnership CMEA Ventures LS Management 2000 L.P. Collier David J Handelsman Karl D. Director 10% Owner | 2014-11-12 16:31:56 | 0 0 | 0 | Form 4 |
| Mizutani Pedro Isamu Director | 2011-07-22 17:33:44 | 0 0 | 0 | Form 3 |